A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib

NCT00996762 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

158

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms, Breast

Interventions

DRUG: lapatinib

Sponsor

GlaxoSmithKline